Last reviewed · How we verify
GL2702 GLARS-NF1
At a glance
| Generic name | GL2702 GLARS-NF1 |
|---|---|
| Also known as | Tamsulosin |
| Sponsor | GL Pharm Tech Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers (PHASE1)
- Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |